ETON
NASD Eton Pharmaceuticals, Inc.$52.01 ↑ +0.52 (+1.01%) Trading Up from the previous close of $51.49, $7.65 below the day’s high of $59.66
- YTD change
- +207.57%
- vs 20-day SMA
- -10.24%
- vs 200-day SMA
- +64.79%
Price ranges
Price & Performance
+36.61 (+162.13%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 21.6% away from all-time highs of $66.37
- ETON is up 208% since the beginning of the year
- ETON is up 139% over the past 12 months
- ETON is down 14% over the past 1 month
- 6% of all ETON investors are betting against ETON
ETON reads not so good: price sits above one of the two key moving averages, the 12-month move is +172.4%.
- Previous minute
- +$0.00
- Last hour
- -$0.29
- Last 5 days
- -8.90%
- vs 8-day SMA
- -9.36%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Eton Pharmaceuticals, Inc. engages in the development, acquisition, and commercialization of prescription drug products. Its products include Biorphen, Alaway Preservative Free, zonisamide oral suspension, topiramate oral suspension, lamotrigine for oral suspension, cysteine injection, and ephedrine ready-to-use injection. The company was founded in April 2017 and is headquartered in Deer Park, IL.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.